P2Y 12 -inhibitor monotherapy after coronary stenting: are all P2Y 12 -inhibitors equal?
Niels M R van der SangenI Tarik KüçükJurriën M Ten BergMarcel Am BeijkRonak DelewiAlexander W den HartogYolande AppelmanNiels Jw VeroudenWouter J KikkertJosé P S HenriquesBimmer E P M ClaessenPublished in: Expert review of cardiovascular therapy (2022)
-inhibitor monotherapy and what the optimal antithrombotic therapy beyond 12 months is.